Hyperkalaemia Severity and ECG Risk
Stratifies hyperkalaemia severity and guides emergency treatment based on potassium level and ECG changes.
Score interpretation
Serum K⁺ below 5.5 mmol/L.
→ No hyperkalaemia treatment needed.
UKKA mild hyperkalaemia, no ECG changes.
→ Treat the cause; review contributing drugs and diet; repeat K⁺.
UKKA moderate hyperkalaemia, no ECG changes.
→ 12-lead ECG; K⁺-lowering treatment per the UKKA acute hyperkalaemia algorithm; repeat K⁺ and monitor.
UKKA severe hyperkalaemia.
→ Emergency: continuous cardiac monitoring and urgent K⁺-lowering treatment per the UKKA algorithm; senior review.
ECG changes of hyperkalaemia (peaked T waves, prolonged PR, wide QRS, sine wave, arrhythmia or arrest).
→ IV calcium to protect the myocardium, then K⁺-lowering treatment per the UKKA algorithm; continuous ECG monitoring; senior / critical care review. Cardiac arrest: follow the ALS hyperkalaemia algorithm.
Interpretation bands for the Hyperkalaemia Risk. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Calcium Gluconate · Electrolyte — Calcium Supplement
- Calcium Gluconate 10% · Electrolyte
- Potassium chloride with calcium chloride and sodium chloride · Crystalloid IV fluid
- Potassium chloride with calcium chloride sodium chloride and sodium lactate · Balanced crystalloid IV fluid
- Calcium carbonate with calcium lactate gluconate · Effervescent calcium supplement
- Patiromer calcium · Potassium binder
- Hyperkalaemia Management · UK Kidney Association Guidelines 2020; NICE CKD Guidelines
- Rhabdomyolysis · Renal Association 2018; UpToDate 2024
- Hypocalcaemia (Adult) · Society for Endocrinology
- SIADH (Endocrine Perspective) · European Hyponatraemia Guidelines 2014
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Acute Kidney Injury (AKI) · KDIGO 2012 / NICE AKI 2019
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.